Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 |
filingDate |
2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c353688bb10f62045de7fdb3c5617745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b7fd4bbec84335debed33adb09590f |
publicationDate |
2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2014013839-A |
titleOfInvention |
5-AMINO [1,4] THIAZINS AS INHIBITORS OF BETA-SECRETASE 1 (BACE 1). |
abstract |
The present invention relates to a compound of formula I having BACE1 inhibitory activity, its manufacture, pharmaceutical compositions containing it and its use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and / or prophylactic treatment of, for example, Alzheimer's disease. |
priorityDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |